CASI Pharmaceuticals Inc Forecast, price target & analysts
CASI Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation
CASI Pharmaceuticals Inc Classifications & Recommendation:
CASI Pharmaceuticals Inc Price Target
| Target Price | $6.00 |
| Price | $2.01 |
| Potential |
198.51%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a CASI Pharmaceuticals Inc price target 2026.
The average CASI Pharmaceuticals Inc target price is $6.00.
This is
198.51%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend CASI Pharmaceuticals Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CASI Pharmaceuticals Inc stock has an average upside potential 2026 of
198.51%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 28.54 | 46.48 |
| 15.76% | 62.85% | |
| Net Margin | -138.94% | -33.44% |
| 50.45% | 75.93% |
1 Analyst has issued a sales forecast CASI Pharmaceuticals Inc 2025 . The average CASI Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
The average CASI Pharmaceuticals Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-39.7m | 26.73% |
|---|---|---|
| 2025 |
$-15.5m
60.81%
Unlock
|
|
Net Margin
| 2024 | -138.94% | 50.45% |
|---|---|---|
| 2025 |
-33.44%
75.93%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.56 | -1.16 |
| 26.73% | 54.69% | |
| P/E | negative | |
| EV/Sales | 2.00 |
The average CASI Pharmaceuticals Inc EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-2.56 | 26.73% |
|---|---|---|
| 2025 |
$-1.16
54.69%
Unlock
|
|
P/E ratio
| Current | ||
|---|---|---|
| 2025 |
-5.60
656.76%
Unlock
|
|
CASI Pharmaceuticals Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
